1. Gallium as a potential candidate for treatment of osteoporosis
- Author
-
Jean-Michel Bouler, Jean-Claude Scimeca, E. Verron, Chimie Et Interdisciplinarité : Synthèse, Analyse, Modélisation (CEISAM), Université de Nantes - UFR des Sciences et des Techniques (UN UFR ST), Université de Nantes (UN)-Université de Nantes (UN)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC), Laboratoire d'ingénierie osteo-articulaire et dentaire (LIOAD), and Université de Nantes (UN)-IFR26-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
media_common.quotation_subject ,Osteoporosis ,Osteoclasts ,chemistry.chemical_element ,Potential candidate ,Gallium ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Pharmacology ,Bone tissue ,Malignancy ,MESH: Bone Density Conservation Agents ,03 medical and health sciences ,0302 clinical medicine ,MESH: Osteoclasts ,[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN] ,[SDV.BC.IC]Life Sciences [q-bio]/Cellular Biology/Cell Behavior [q-bio.CB] ,Drug Discovery ,medicine ,Animals ,Humans ,MESH: Animals ,[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Biochemistry [q-bio.BM] ,[SDV.IB.BIO]Life Sciences [q-bio]/Bioengineering/Biomaterials ,Internalization ,030304 developmental biology ,media_common ,0303 health sciences ,MESH: Humans ,Bone Density Conservation Agents ,business.industry ,MESH: Gallium ,[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Molecular biology ,medicine.disease ,3. Good health ,Clinical trial ,medicine.anatomical_structure ,[SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system ,chemistry ,030220 oncology & carcinogenesis ,Cancer research ,business ,MESH: Osteoporosis - Abstract
International audience; Gallium (Ga) is a semi-metallic element that displays antitumor, antiresorptive, anti-inflammatory and immunosuppressive properties. Among all these properties, antitumor properties were the most extensively applied and have shown efficacy in treatment of Paget's disease, myeloma and hypercalcemia in cases of malignancy. By contrast, no clinical trials have been conducted in prevention and/or treatment of osteoporosis. In this article I focus on Ga effects on bone tissue and cells, as well as on molecular mechanisms governing Ga internalization into cells. Eventually, the potential of Ga as an antiosteoporotic agent is discussed.
- Published
- 2012